novocure | Novocure | cancer therapy: Tumor Treating Fields (TTFields)

Keyword	CPC	PCC	Volume	Score	Length of keyword
novocure	0.53	0.4	3341	10	8

Keyword Research: People who searched novocure also searched

Keyword	CPC	PCC	Volume	Score
novocure	0.88	0.6	7230	45
novocure stock	0.24	0.9	7504	43
novocure stock price	1.86	0.7	9937	32
novocure news	1.35	0.9	9887	33
novocure careers	0.33	0.7	8130	93
novocure optune	1.57	0.2	4961	73
novocure website	1.7	0.5	6692	13
novocure gmbh	1.12	0.2	1802	15
novocure products	0.22	0.1	7073	19
novocure limited	1.84	0.8	2151	49
novocure clinical trials	1.39	0.1	2178	53
novocure portsmouth nh	0.64	0.9	4592	78
novocure yahoo finance	0.11	0.1	4994	92
novocure aktie	1.54	0.8	4925	24
novocure stock forecast	1.32	0.7	5215	83
novocure stock google	0.14	1	3430	75
novocure wikipedia	1.9	0.5	4331	49
novocure news today	0.91	0.4	8350	36
novocure pipeline	0.42	0.9	8272	21
novocure investor relations	0.28	0.4	3435	32

Novocure | cancer therapy: Tumor Treating Fields (TTFields)
novocure.com

https://www.novocure.com/

Web3 days ago · The science of Tumor Treating Fields extends beyond glioblastoma and mesothelioma. Novocure has ongoing or completed clinical trials investigating our therapy in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer and ovarian cancer.

DA: 74 PA: 19 MOZ Rank: 24

Novocure | making a difference in cancer | NVCR company info
novocure.com

https://www.novocure.com/about-us/

Web4 days ago · Novocure is a global oncology company striving to extend survival in aggressive forms of cancer with our innovative Tumor Treating Fields (TTFields) therapy.

DA: 89 PA: 3 MOZ Rank: 41

Novocure Announces Presentations on Tumor Treating Fields Therapy
novocure.com

https://www.novocure.com/novocure-announces-presentations-on-tumor-treating-fields-therapy-including-new-clinical-data-and-real-world-evidence-at-2023-society-for-neuro-oncology-annual-meeting/

WebNov 10, 2023 · ROOT, Switzerland– (BUSINESS WIRE)– Novocure (NASDAQ: NVCR) today announced that research on Tumor Treating Fields (TTFields) therapy, including new data from the phase 2 2-THE-TOP trial and real-world evidence from patients diagnosed with glioblastoma (GBM) and other central nervous system tumors (CNS), will be presented at the 2023 ...

DA: 40 PA: 38 MOZ Rank: 4

Novocure Announces Pivotal LUNAR Study in Non-Small Cell Lung Cancer
novocure.com

https://www.novocure.com/novocure-announces-pivotal-lunar-study-in-non-small-cell-lung-cancer-met-primary-overall-survival-endpoint/

WebJan 5, 2023 · Novocure Announces Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint. January 5, 2023. The LUNAR study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in overall survival. The full LUNAR data will be presented at a future medical congress.

DA: 50 PA: 76 MOZ Rank: 84

Novocure pipeline | oncology clinical trials with TTFields
novocure.com

https://www.novocure.com/our-pipeline/

Web4 days ago · The Novocure clinical pipeline includes phase-3 clinical trials LUNAR, METIS, PANOVA, TRIDENT and investigates Tumor Treating Fields in solid tumor cancers.

DA: 42 PA: 85 MOZ Rank: 64